Cochlear Implantation for Profound Hearing Loss After Multimodal Treatment for Neuroblastoma in Children
Nam-Gyu Ryu, Il Joon Moon, Young Soo Chang, Byoung Kil Kim, Won-Ho Chung, Yang-Sun Cho, Sung Hwa Hong
Clin Exp Otorhinolaryngol. 2015;8(4):329-334.   Published online 2015 Nov 10     DOI: https://doi.org/10.3342/ceo.2015.8.4.329
Citations to this article as recorded by Crossref logo
Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor
Bartosz Polski, Patrycja Sosnowska-Sienkiewicz, Jarosław Szydłowski, Danuta Januszkiewicz-Lewandowska
Audiology and Neurotology.2023; 28(1): 32.     CrossRef
Role of estrogen receptor alpha in MEHP-induced proliferation and invasion of SH-SY5Y cells
Shuangyu Guo, Bo Zhang, Wen Qi, Xiaolian Cao, Yixuan Xu, Xueting Zhang, Xu Li, Liting Zhou, Lin Ye
Toxicology.2021; 453: 152734.     CrossRef
Preimplantation genetic diagnosis of hereditary hearing loss: a narrative review
Xiaonan Wu, Jing Guan, Hongmei Peng, Qiuju Wang
Journal of Bio-X Research.2021; 4(4): 137.     CrossRef
Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca2+‑signaling
Yang Di, Tao Xu, Yuan Tian, Tingting Ma, Donghao Qu, Yan Wang, Yuhan Lin, Dongyan Bao, Li Yu, Shuangyue Liu, Aimei Wang
International Journal of Molecular Medicine.2020; 46(2): 806.     CrossRef
Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants
Amy E. Armstrong, Karina Danner-Koptik, Shannon Golden, Jennifer Schneiderman, Morris Kletzel, Jennifer Reichek, Yasmin Gosiengfiao
Journal of Pediatric Hematology/Oncology.2018; 40(1): 31.     CrossRef
Late Effects and Survivorship Issues in Patients with Neuroblastoma
Danielle Friedman, Tara Henderson
Children.2018; 5(8): 107.     CrossRef